BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24657273)

  • 1. Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases.
    Sipahi OR; Kahraman H; Mermer S; Pullukcu H; Tasbakan M; Arda B; Yamazhan T; Yurtseven T; Aydemir S; Ulusoy S
    Int J Infect Dis; 2014 Jun; 23():16-9. PubMed ID: 24657273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged and high dosage of tigecycline - successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report.
    Tsachouridou O; Georgiou A; Nanoudis S; Chrysanthidis T; Loli G; Morfesis P; Zebekakis P; Metallidis S
    J Med Case Rep; 2017 Jul; 11(1):186. PubMed ID: 28687078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.
    Montravers P; Bassetti M; Dupont H; Eckmann C; Heizmann WR; Guirao X; García MS; Capparella MR; Simoneau D; Bodmann KF
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii15-24. PubMed ID: 23772042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tigecycline in critically ill patients with serious nosocomial intra-abdominal infections.
    Maseda E; Denis SE; Riquelme A; Gilsanz F
    Rev Esp Quimioter; 2013 Mar; 26(1):56-63. PubMed ID: 23546465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies.
    Eckmann C; Montravers P; Bassetti M; Bodmann KF; Heizmann WR; Sánchez García M; Guirao X; Capparella MR; Simoneau D; Dupont H
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii25-35. PubMed ID: 23772043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
    Ku K; Pogue JM; Moshos J; Bheemreddy S; Wang Y; Bhargava A; Campbell M; Khandker N; Lephart PR; Chopra T; Hayakawa K; Martin ET; Abreu-Lanfranco O; Dhar S; Kaye KS; Marchaim D
    Am J Infect Control; 2012 Dec; 40(10):983-7. PubMed ID: 22440526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
    Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: susceptibility and clinical outcome.
    Kim NH; Hwang JH; Song KH; Choe PG; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
    Scand J Infect Dis; 2013 Apr; 45(4):315-9. PubMed ID: 23113680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.
    Bassetti M; Eckmann C; Bodmann KF; Dupont H; Heizmann WR; Montravers P; Guirao X; Capparella MR; Simoneau D; Sánchez García M
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii5-14. PubMed ID: 23772047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis.
    Zarrouk V; Feydy A; Sallès F; Dufour V; Guigui P; Redondo A; Fantin B
    Rheumatology (Oxford); 2007 Feb; 46(2):292-5. PubMed ID: 16877464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When and how to operate on spondylodiscitis: a report of 13 patients.
    Mavrogenis AF; Igoumenou V; Tsiavos K; Megaloikonomos P; Panagopoulos GN; Vottis C; Giannitsioti E; Papadopoulos A; Soultanis KC
    Eur J Orthop Surg Traumatol; 2016 Jan; 26(1):31-40. PubMed ID: 26190644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious spondylodiscitis.
    Cottle L; Riordan T
    J Infect; 2008 Jun; 56(6):401-12. PubMed ID: 18442854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline for the treatment of Acinetobacter infections: a case series.
    Gallagher JC; Rouse HM
    Ann Pharmacother; 2008 Sep; 42(9):1188-94. PubMed ID: 18614749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious spondylodiscitis - a case series analysis.
    Garkowski A; Zajkowska A; Czupryna P; Lebkowski W; Letmanowski M; Gołębicki P; Moniuszko A; Ustymowicz A; Pancewicz S; Zajkowska J
    Adv Med Sci; 2014 Mar; 59(1):57-60. PubMed ID: 24797976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage.
    Chen LY; Chen TC; Chen YH; Lin CY; Lin WR; Lu PL
    J Microbiol Immunol Infect; 2011 Oct; 44(5):352-7. PubMed ID: 21524975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of tigecycline for treatment of culture-negative pyogenic vertebral osteomyelitis.
    Seyman D; Berk H; Sepın-Ozen N; Kızılates F; Turk CC; Buyuktuna SA; Inan D
    Infect Dis (Lond); 2015; 47(11):783-8. PubMed ID: 26107887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.